Abstract:Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is the most common subtype of gastric lymphoma. Most gastric MALT lymphomas are characterized by their association with the Helicobacter pylori (HP) infection and are cured by first-line HP eradication therapy (HPE). Several studies have been conducted to investigate why most gastric MALT lymphomas remain localized, are dependent on HP infection, and show HP-specific intratumoral T-cells (e.g., CD40-mediated signaling, T-helper-2 (Th2)-type cytokines, chemokines, costimulatory molecules, and FOXP3+ regulatory T-cells) and their communication with B-cells. Furthermore, the reason why the antigen stimuli of these intratumoral T-cells with tonic B-cell receptor signaling promote lymphomagenesis of gastric MALT lymphoma has also been investigated. In addition to the aforementioned mechanisms, it has been demonstrated that the translocated HP cytotoxin-associated gene A (CagA) can promote B-cell proliferation through the activation of Src homology-2 domain-containing phosphatase (SHP-2) phosphorylation-dependent signaling, extracellular-signal-regulated kinase (ERK), p38 mitogen-activated protein kinase (MAPK), B-cell lymphoma (Bcl)-2, and Bcl-xL. Furthermore, the expression of CagA and these CagA-signaling molecules is closely associated with the HP-dependence of gastric MALT lymphomas (completely respond to first-line HPE). In this article, we summarize evidence of the classical theory of HP-reactive T-cells and the new paradigm of direct interaction between HP and B-cells that contributes to the HP-dependent lymphomagenesis of gastric MALT lymphomas. Although the role of first-line HPE in the treatment of HP-negative gastric MALT lymphoma remains uncertain, several case series suggest that a proportion of HP-negative gastric MALT lymphomas remains antibiotic-responsive and is cured by HPE. Considering the complicated interaction between microbiomes and the genome/epigenome, further studies on the precise mechanisms of HP- and other bacteria-directed lymphomagenesis in antibiotic-responsive gastric MALT lymphomas are warranted.

[Research Progress on the Etiology and Pathogenesis of MALT Lymphoma].

Diagnosis and Treatment of Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma

[Analysis of 37 Pathological and Clinic Data of Extranodal Marginal Zone B-cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT)].

Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma in the Gastrointestinal Tract in the Modern Era

Xuebiao Huang, Zackery Zhang 3, Hongxiang Liu, Hongtao Ye, Shih Sung Chuang 4

Analysis of Prognostic Factors of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue

Role of Helicobacter Pylori Virulence Factor Cytotoxin-Associated Gene A in Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

Extranodal lymphomas: the MALT concept

Molecular pathogenesis of lymphomas of mucosa-associated lymphoid tissue—from (auto)antigen driven selection to the activation of NF-κB signaling

A case of colonic MALT lymphoma with intra-abdominal abscess and lung metastasis: A case report

Clinical progress and pathological features of mucosa-associated lymphoid tissue lymphoma

[Clinical features and prognosis of mucosa-associated lymphoid tissue lymphoma].

Recent Advances in the Genetic of MALT Lymphomas

MALT lymphoma: A paradigm of NF-κB dysregulation

Therapy of gastric mucosa associated lymphoid tissue lymphoma

Novel Insights of Lymphomagenesis of Helicobacter pylori-Dependent Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

Pathological Features, IgM Expression and MYD88 L265P Mutation in MALT Lymphoma

[Diagnosis and Treatment of Gastric Mucosa-associated Lymphoid Tissue Lymphoma]

Histopathological staging and differential diagnosis of marginal zone lymphoma of gastric mucosa-associated lymphoid tissue

Helicobacter pylori and gastric mucosa-associated lymphoid tissue lymphoma: recent progress in pathogenesis and management

Progress on the Study of Molecular Genetics of MALT Lymphomas